This is an exciting award for the company with the largest percentage increase in citations for antibodies. To qualify for this category, a company must have at least 10 citations in the previous year. This award was designed to recognise suppliers with a smaller citation share who might be about to take off in this market.

We are thrilled to announce that Elabscience has been named CiteAb Antibody Supplier to Watch in 2021.

From the data generated through CiteAb, we are able to gain a really clear picture of the way antibodies are used around the world. We can tell which countries are investing most in research using antibodies, which companies are seeing growth or decline, which antibodies are most successful and which areas of research are seeing growth.

For this award we looked at CiteAb data for the antibody supplier with the largest increase in citations between 2018 and 2019.

Dr Andrew Chalmers, founder of CiteAb, said: “Congratulations to Elabscience for being named CiteAb Antibody Supplier to Watch in 2021. This is a very exciting achievement, with data for the company demonstrating a quick upward trajectory in use of its antibody products. I wish the whole team at Elabscience the very best for the year to come, and many congratulations on their win.”